Leading medical diagnostics/research company announces the availability
of two new monoclonal antibodies EGFR, clone F4 and VEGF, clone VG-1.
DEDHAM, Mass., March 16 /PRNewswire/ -- Signet Laboratories, Inc., a
leading medical diagnostics/research company specializing in the development
of monoclonal antibodies and diagnostic assays for cancer, infectious disease,
and neurodegenerative disease, today announced the availability of two new
monoclonal antibodies, EGFR, clone F4 and VEGF, clone VG-1.
EGFR, clone F4, has been implicated in the development and progression of
a number of human solid tumors including lung, breast, prostate, colon, ovary,
head, and neck.
VEGF, clone VG-1, is a secreted glycoprotein that is a potent and specific
mitogen for vascular endothelial cells that stimulates angiogenesis during
embryonic development and tumor formation.
Signet's EGFR and VEGF antibodies offer researchers a valuable tool for
cancer research. These antibodies complement Signet's current product
portfolio which includes markers such as D2-40, Cyclin D1, Cyclin E, HE4, and
Hepsin.
About Signet Laboratories, Inc.
Signet Laboratories, Inc. (Signet, Dedham, MA) is a leading medical
diagnostics/research company specializing in the development of monoclonal
antibodies and diagnostic assays for cancer, infectious disease, and
neurodegenerative disease. Signet was created in 1989 as a commercial spinout
of Johnson & Johnson's Cambridge Research Laboratories, Inc. (CRL, Cambridge,
MA).
The Company was founded to continue the mission originally established at
CRL -- the early detection and recurrence monitoring of patients with cancer
and infectious disease. Signet has developed patented technology for
diagnosis and recurrence monitoring and for risk assessment of asymptomatic
patients in these areas. For more than a decade, the Company has aggressively
maintained licensing and development programs, which are responsible for its
broad patent and intellectual estate.
Contact Information
Company Contact Immunohistochemistry Contact
Colleen Scott Angela Thomas
Signet Laboratories, Inc. Signet Laboratories, Inc.
180 Rustcraft Road 180 Rustcraft Road
Dedham, MA 02026 Dedham, MA 02026
Phone: 781.915.1404 Phone: 781.915.1417
Fax: 781.461.2456 Fax: 781.461.2456
cscott@signetlabs.com athomas@signetlabs.com
SOURCE Signet Laboratories, Inc.
 back to top
Related links:
http://www.signetlabs.com
CONTACT:
Company Contact: Colleen Scott, Phone:
+1-781-915-1404, Fax: +1-781-461-2456, cscott@signetlabs.com ,
or Immunohistochemistry Contact: Angela Thomas, Phone:
+1-781-915-1417, Fax: +1-781-461-2456, athomas@signetlabs.com ,
both of Signet Laboratories, Inc.
|
